Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01WGJ
|
||||
| Former ID |
DNC002527
|
||||
| Drug Name |
Daidzin
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Terminated | [546409] | ||
| Formula |
C21H20O9
|
||||
| Canonical SMILES |
C1=CC(=CC=C1C2=COC3=C(C2=O)C=CC(=C3)OC4C(C(C(C(O4)CO)O)<br />O)O)O
|
||||
| InChI |
1S/C21H20O9/c22-8-16-18(25)19(26)20(27)21(30-16)29-12-5-6-13-15(7-12)28-9-14(17(13)24)10-1-3-11(23)4-2-10/h1-7,9,16,18-23,25-27H,8H2
|
||||
| InChIKey |
KYQZWONCHDNPDP-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 552-66-9
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Aldehyde dehydrogenase, mitochondrial | Target Info | Inhibitor | [551393] | |
| KEGG Pathway | Glycolysis / Gluconeogenesis | ||||
| Pentose and glucuronate interconversions | |||||
| Ascorbate and aldarate metabolism | |||||
| Fatty acid degradation | |||||
| Valine, leucine and isoleucine degradation | |||||
| Lysine degradation | |||||
| Arginine and proline metabolism | |||||
| Histidine metabolism | |||||
| Tryptophan metabolism | |||||
| beta-Alanine metabolism | |||||
| Glycerolipid metabolism | |||||
| Pyruvate metabolism | |||||
| Metabolic pathways | |||||
| Biosynthesis of antibiotics | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.